Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Higher Cell-Free DNA Yields on Liquid Biopsy Testing in Glioblastoma Patients

1 Jan 2025

Abstract excerpt

BACKGROUND: Minimally invasive molecular profiling using cell-free DNA (cfDNA) is increasingly important to the management of cancer patients; however, low sensitivity remains a major limitation, particularly for brain tumor patients. Transiently attenuating cfDNA clearance from the body-thereby, allowing more cfDNA to be sampled-has been proposed to improve the performance of liquid biopsy diagnostics. However,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39749509
DOI: 10.1093/clinchem/hvae178

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Higher Cell-Free DNA Yields on Liquid Biopsy Testing in Glioblastoma PatientsPMID 39749509Read ↗

Cell-Free DNA Sequencing Uncovers the Longitudinal Consequences of Temozolomide Treatment and Host Co-Culture in GlioblastomaSemantic proximity Read ↗

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.Semantic proximity Read ↗

A hitchhiker’s guide to cell-free DNA biologySemantic proximity Read ↗

Longitudinal glioma monitoring via cerebrospinal fluid cell-free DNA: one patient at a timeSemantic proximity Read ↗

The coming of age of liquid biopsy in neuro-oncology.Semantic proximity Read ↗

Tapping into the genome: the role of CSF ctDNA liquid biopsy in gliomaSemantic proximity Read ↗

A liquid biopsy platform for detecting gene-gene fusions as glioma diagnostic biomarkers and drug targetsSemantic proximity Read ↗

Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?Semantic proximity Read ↗

MR-Guided Focused Ultrasound-Enhanced Liquid Biopsy (Sonobiopsy) for the Definitive Differentiation of True Progression from Pseudoprogression in Glioblastoma: A Prospective Phase II Clinical TrialSemantic proximity Read ↗

Detection of Brain Cancer Using Genome-wide Cell-free DNA FragmentomesSemantic proximity Read ↗

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.Semantic proximity Read ↗

The emerging role of circulating tumor DNA in brain tumor researchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.